Just two weeks after a California jury awarded a dying woman $29 million having decided that asbestos in talc used in Johnson & Johnson’s Baby Powder caused her to develop mesothelioma, the corporation finished an active month with a mixed record overall.
Three cases alleging the same link were waiting to be heard in state courts in Oklahoma, New York, and California. They were settled under ...
continue reading...
“We are disappointed with today’s verdict and will pursue an appeal because Johnson’s Baby Powder does not contain asbestos or cause cancer.” Another jury has found Johnson & Johnson’s Baby Powder responsible for a case of mesothelioma and another statement has been issued by the corporation denying that its products contain asbestos.
The verdict marks J&J’s seventh loss in the matter, and while overall ...
continue reading...
A new lawsuit alleging a link between Johnson & Johnson Baby Powder and mesothelioma-causing asbestos fibers took a surprising turn late last month. That was when lawyers for the world’s largest healthcare goods manufacturer and lawyers for a man dying of mesothelioma began debating whether there was a racial aspect to the case that needed to be exposed.
An attorney for Richardo Rimondi, a Peruvian immigrant and father ...
continue reading...Johnson & Johnson and its subsidiary company Ethicon were hit with a $41 million vaginal mesh verdict last month. Of that amount, some $25 million was awarded in punitive damages against the company.
The plaintiff had undergone surgery to implant the device in 2007. Since implantation, she has suffered numerous debilitating side effects including pain and discomfort, bleeding, infections, and pain ...
continue reading...
In a previous post, we discussed the $4.7 billion verdict recently awarded to 22 plaintiffs who claimed that asbestos present in Johnson & Johnson’s Baby Powder caused them to develop ovarian cancer. The verdict was one of the largest in history and sent J&J stock tumbling. Even in the face of such a verdict, J&J remained steadfast and even defiant in its tone. The company issued ...
If Johnson & Johnson investors and company executives thought 2018 was bad, they may not have seen anything yet. With a massive verdict of over $4 billion leading the way and more than 10,000 additional lawsuits waiting the wings, J&J finds itself in a battle to not only reclaim its wholesome and trustworthy image, but perhaps even in a battle for its ...
